Growth factors and mitogen-activated protein kinases

Hypertension

Volumn 31, Issue 1 II SUPPL., 1998, Pages 152-161

  Force, Thomas ^a   Bonventre, Joseph V ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angiotensin II; Endothelin; G protein coupled receptors; Growth factors; MAP kinases; Stress activated protein kinases

Indexed keywords

ANGIOTENSIN; ENDOTHELIN; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; TRANSCRIPTION FACTOR; GROWTH PROMOTOR; PROTEIN KINASE (CALCIUM,CALMODULIN);

ANIMAL CELL; ANIMAL MODEL; CELL CYCLE; CONFERENCE PAPER; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME KINETICS; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; HUMAN; HYPERTROPHY; MAMMAL; METABOLISM; PHYSIOLOGY; REVIEW; VERTEBRATE;

ANIMALS; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; CELL DIVISION; GROWTH SUBSTANCES; HUMANS; HYPERTROPHY; MAMMALS; SIGNAL TRANSDUCTION; VERTEBRATES;

EID: 0031600501     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.31.1.152     Document Type: Conference Paper

References (108)

1. Ray LB, Sturgill TW. Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vivo. Proc Natl Acad Sci U S A. 1988;85:3753-3757.
2. Denhardt DT. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochem J. 1996;318:729-747.
3. Liao D-F, Monia B, Dean N, Berk BC. Protein kinase C-ζ mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem. 1997;272:6146-6150.
4. Kyriakis JM, Force TL, Rapp UR, Bonventre JV, Avruch J. Mitogen regulation of c-Raf-1 protein kinase activity toward mitogen-activated protein kinase kinase. J Biol Chem. 1993;268:16009-16019.
5. Wang Y, Simonson MS, Pouyssegur J, Dunn MJ. Endothelin rapidly stimulates mitogen-activated protein kinase activity in rat mesangial cells. Biochem J. 1992;287:589-594.
6. Wang Y, Rose PM, Webb ML, Dunn MJ. Endothelin stimulates mitogen-activated protein kinase cascade through either ETA or ETB. Am J Physiol. 1994;267:C1130-C1135.
7. 2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase. J Biol Chem. 1994;269:5693-5698.
8. q-protein-coupled pathway. J Biol Chem. 1995;270:8984-8990.
9. 2 in norepinephrine-induced arachidonic acid release in rabbit aortic smooth muscle cells. J Biol Chem. 1996;271:30149-30157.
10. Wan Y, Kurosaki T, Huang X. Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors. Nature. 1996;380: 541-544.
11. Heldin C-H. Dimerization of cell surface receptors in signal transduction. Cell. 1995;80:213-223.
12. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990;61:203-212.
13. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature. 1993;363: 45-51.
14. ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature. 1993;364:308-313.
15. Leevers SJ, Paterson HF, Marshall CJ. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature. 1994;369:411-414.
16. Stokoe D, Macdonald SG, Cadwallader K, Symons M, Hancock JF. Activation of Raf as a result of recruitment to the plasma membrane. Science. 1994;264:1463-1467.
17. Liu D, Bienkowska J, Petosa C, Collier RJ, Fu H, Liddington R. Crystal structure of the zeta isoform of the 14-33-3 protein. Nature. 1995;376: 191-194.
18. Xiao B, Smerdon SJ, Jones DH, Dodson GG, Soneji Y, Aitken A, Gamblin SJ. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature. 1995;376:188-191.
19. Li S, Janosch P, Tanji M, Rosenfeld G, Waymire JC, Mischak H, Kolch W, Sedivy JM. Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins. EMBO J. 1995;14:685-696.
20. Luo Z, Tzivion G, Belshaw PJ, Vavvas D, Marshall M, Avruch J. Oligomerization activates c-Raf-1 through Ras dependent mechanism. Nature. 1996;383:181-185.
21. Farrar MA, Ila-Alberola J, Perlmutter RM. Activation of the Raf-1-kinase cascade by coumermycin-induced dimerization. Nature. 1996;383: 178-181.
22. Marshall CJ. Raf gets it together. Nature. 1996;383:127-128.
23. Daum G, Eisenmann-Tappe I, Fries H-W, Troppmair J, Rapp UR. The ins and outs of Raf kinases. Trends Biol Sci. 1994;19:474-480.
24. Kyriakis JM, App H, Zhang X, Banerjee P, Brautigan DL, Rapp UR, Avruch J. Raf-1 activates MAP kinase-kinase. Nature. 1992;358:417-421.
25. Sturgill TW, Ray LB, Erikson E, Maller JL. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature. 1988;334:715-718.
26. rsk isoform with a unique N-terminal sequence: growth factor stimulated kinase function and nuclear translocation. Mol Cell Biol. 1995;15:4353-4363.
27. Nemenoff RA, Winitz S, Qian N-X, Van Putten V, Johnson GL, Heasley LE. Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem. 1993;268:1960-1964.
28. Lin L-L, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 1993;72:269-278.
29. Takishima K, Griswold-Prenner I, Ingebritsen T, Rosner MR. Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated 'MAP' kinase. Proc Natl Acad Sci U S A. 1991;88: 2520-2524.
30. Fukunaga R, Hunter T. Mnk1, new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 1997;16:1921-1433.
31. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 1997;16:1909-1920.
32. Flynn A, Proud CG. The role of elF4 in cell proliferation. Cancer Surv. 1996;27:293-310.
33. Minich WB, Balasta ML, Goss DJ, Rhoads RE. Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor elF-4E. Proc Natl Acad Sci U S A. 1994;91: 7668-7672.
34. Lenormand P, Sardet C, Pages G, L'Allemain G, Brunet A, Pouyssegur J. Growth factors induce nuclear translocation of MAP kinases (p42 and p44) but not of their activator MAP kinase kinase (p45) in fibroblasts. J Cell Biol. 1993;122:1079-1088.
35. Gonzalez F, Seth A, Raden D, Bowman D, Fay F, Davis R. Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J Cell Biol. 1993;122: 1089-1101.
36. Meloche S, Pages G, Pouyssegur J. Biphasic and synergistic activation of p44MAPK (ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol Endocrinol. 1992;6:845-854.
37. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995;9: 726-735.
38. Treisman R. Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol. 1996;8:205-215.
39. Treisman R. Journey to the surface of the cell: Fos regulation and the SRE. EMBO J. 1995;14:4905-4913.
40. TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature. 1992;358:414-416.
41. Wasylyk B, Hahn SL, Giovane A. The Ets family family of transcription factors. Eur J Biochem. 1993;211:7-18.
42. Werner MH, Clore M, Fisher CL, Fisher RJ, Trinh L, Shiloach J, Gronenborn AM. The solution structure of the human ETS1-DNA complex reveals a novel mode of binding and true side chain intercalation. Cell. 1995;83:761-771.
43. Chen R-H, Sarnecki C, Blenis J. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol. 1992;12:915-927.
44. Xing J, Ginty DD, Greenberg ME. Coupling of the RAS-MAPK pathways to gene activation by RSK2, a growth factor-regulated CREB kinase. Science. 1996;273:959-960.
45. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature. 1996; 379:557-560.
46. Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrel LM, Lefkowitz RJ. Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. J Biol Chem. 1997;272: 19125-19132.
47. Force T, Kyriakis JM, Avruch J, Bonventre JV. Endothelin, vasopressin, and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and -independent pathways in glomerular mesangial cells. J Biol Chem. 1991;266:6650-6656.
48. 47a. Herman WH, Simonson MS. Nuclear signaling by endothelin-1. J Biol Chem. 1995;270:11654-11661.
49. 47b. Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J. A role for Pyk2 and Src in linking G-protein coupled receptors with MAP kinase activation. Nature. 1996;383:547-550.
50. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S. Protein kinase C delta activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem. 1996;271:23512-23519.
51. Lopez-Ilasaca M, Crespo P, Pellici Giuseppe P, Gutkind Silvio J, Wetzker R. Linkage of G protein-coupled receptors to the MAPK signaling pathway through P1 3-kinase. Science. 1997;275:394-397.
52. Natarajan R, Gonzales N, Lanting L, Nadler JL. Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle hypertrophy. Hypertension. 1994;23:142-147.
53. Wen Y, Nadler JL, Gonzales N, Scott S, Clauser E, Natarajan R. Mechanisms of ANG II-induced mitogenic responses: role of 12-lipoxygenase and biphasic MAP kinase. Am J Physiol. 1996;271:C1212-C1220.
54. Cowley S, Paterson H, Kemp P, Marshall C. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 1994;77:841-852.
55. Mansour S, Matten W, Hermann A, Candia J, Rong S, Fukasawa K, Woude G. Ahn N. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science. 1994;265:966-970.
56. Marshall C. Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995; 80:179-185.
57. Pages G, Lenormand P, L'Allemain G, Chambard J-C, Meloche S, Pouyssegur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci U S A. 1993; 90:8319-8323.
58. Grana X, Reddy EP. Cell cycle control in mammalian cells. Oncogene. 1995;11:211-219.
59. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/44 MAPK and negatively by the p38/HOG MAPK pathway. J Biol Chem. 1996;271:20608-20616.
60. Cip1. Mol Cell Biol. 1997;17: 5598-5611.
61. Cip1. Mol Cell Biol. 1997;17: 5588-5597.
62. Hunter JJ, Tanaka N, Rockman HA, Ross J Jr , Chien KR. Ventricular expression of the MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem. 1995; 270:23173-23178.
63. Thorburn J, Carlson M, Mansour SJ, Chien KR, Ahn NG, Throburn A. Inhibition of a signaling pathway in cardiac muscle cells by active mitogen activated protein kinase kinase. Mol Biol Cell. 1995;6:1479-1490.
64. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem. 1995;270:14843-14846.
65. Sun H, Tonks NK, Bar-Sagi D. Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1. Science. 1994;266:285-288.
66. Sun H, Charles C, Lau L, Tonks N. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell. 1993;75:487-493.
67. Duff JL, Monia BP, Berk BC. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells: effect of actinomycin D and antisense olionucleotides. J Biol Chem. 1995;270:7161-7166.
68. Graves LM, Bornfeldt KE, Raines EW, Potts BC, Macdonald SG, Ross R, Krebs EG. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc Natl Acad Sci U S A. 1993;90: 10300-10304.
69. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science. 1993;262:1065-1069.
70. Cook SJ, McCormick F. Inhibition by cAMP of Ras-dependent activation of Raf. Science. 1993;262:10691072.
71. Vossier MR, Yao H, York RD, Pan M-G, Rim CS, Stork PJS. cAMP activates MAP kinase, and Elk-1 through a B-Raf-, and Rap-1-dependent pathway. Cell. 1997;89:73-82.
72. Takahashi T, Kawahara Y, Okuda M, Yokoyama M. Increasing cAMP antagonizes hypertrophic response to angiotensin II without affecting Ras and MAP kinase activation in vascular smooth muscle cells. FEBS Lett. 1996;397:89-92.
73. Clowes AW, Karnovsky MJ. Suppression by heparin of smooth muscle proliferation in injured arteries. Nature. 1977;265:625-626.
74. + exchange and growth of pulmonary artery smooth muscle cells. Am J Physiol. 1996;270:L260-L265.
75. Pukac LA, Carter JE, Ottlinger ME, Karnovsky MJ. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells. J Cell Physiol. 1997;172:69-78.
76. Dubey RK, Zhang HY, Reddy SR, Boegehold MA, Kotchen TA. Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats. Am J Physiol. 1993;R726-R732.
77. Yoshioka S, Nishino H, Shiraki T, Ikeda K, Koike H, Okuno A, Wada M, Fujiwara T, Horikoshi H. Antihypertensive effects of CS-045, a new oral antidiabetic agent. Metabolism. 1993;42:75-80.
78. Zhang H, Reddy S, Kotchen T. Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity. Hypertension. 1994;24:106-110.
79. Law RE, Meehan WP, Xi X-P, Graf K, Wuthrich DA, Coats W, Faxon D, Hsueh WA. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J Clin Invest. 1996;98:1897-1905.
80. Graf K, Xi X-P, Hsueh WA, Law RE. Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells. FEBS Lett. 1997;400:119-121.
81. Dérijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 1994;76:1025-1037.
82. Kyriakis JM, Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem. 1996;271:24313-24316.
83. Kyriakis JM, Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. BioEssays. 1996;18:567-577.
84. Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM. Stress-activated protein kinases in cardiovascular disease. Circ Res. 1996;78: 947-953.
85. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 1994;369:156-160.
86. Pombo CP, Bonventre JV, Avruch J, Woodgett JR, Kyriakis JM, Force T. The stress-activated protein kinases (SAPKs) are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem. 1994;269:26546-26551.
87. Morooka H, Bonventre JV, Pombo CM, Kyriakis JM, Force T. Ischemia and reperfusion enhance ATF-2 and c-Jun binding to cAMP response elements and to an AP-1 binding site from the c-jun promoter. J Biol Chem. 1995;270:30084-30092.
88. Yin T, Sandhu G, Wolfgand CD, Burner T, Webb RL, Rigel DF, Hai T, Whelan J. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem. 1997;272:19943-19950.
89. Xu Q, Liu Y, Gorospe M, Udelsman R, Holbrook J. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest. 1996;97:508-514.
90. Zohn IE, Yu H, Li X, Cox AD, Earp HS. Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase. Mol Cell Biol. 1995;15:6160-6168.
91. Shapiro PS, Evans JN, Davis RJ, Posada JA. The seven-transmembrane-spanning receptors for endothelin and thrombin cause proliferation of airway smooth muscle cells and activation of the extracellular regulated kinase and c-Jun NH2-terminal kinase groups of mitogen-activated protein kinases. J Biol Chem. 1996;271:5750-5754.
92. Araki S, Haneda M, Togawa M, Kikkawa R. Endothelin-1 activates c-Jun NH2-terminal kinase in mesangial cells. Kidney Int. 1997;51: 631-639.
93. Sánchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM, Zon LI. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-jun. Nature. 1994;372:794-797.
94. Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ, Davis RJ. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 1995;267:682-685
95. Lange-Carter CA, Johnson GL. Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science. 1994;265:1458-1461.
96. Van M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR, Templeton DJ. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature. 1994;372:798-800.
97. Zhang S, Han J, Sells MA, Chernoff J, Knaus UG, Ulevitch RJ, Bokoch GM. Rho family GTPases regulate p38 MAP kinase through the downstream mediator Pak1. J Biol Chem. 1995;270:23934-23936.
98. Pombo C, Kehrl J, Sanchez I, Katz P, Avruch J, Zon L, Woodgett J, Force T, Kyriakis J. Activation of the SAPK pathway by the human STE20 homolog germinal centre kinase. Nature. 1995;377:750-754.
99. Whitmarsh AJ, Yang S-H, Su M-S, Sharrocks AD, Davis RJ. Role of p38 and JNK mitogen-activated protein kinases in activation of ternary complex factors. Mol Cell Biol. 1997;17:2360-2371.
100. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb M. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 1996;15:4629-4642.
101. Saklatvala J, Rawlinson L, Waller RJ, Sarsfield S, Lee JC, Morton LF, Barnes MJ, Farndale RW. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem. 1996;271:6586-6589.
102. Kramer RM, Roberts EF, Um SL, Borsch-Haubold AG, Watson SP, Fisher MJ, Jakubowski JA. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 in thrombin-stimulated platelets. J Biol Chem. 1996;271:27723-27729.
103. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995; 270:1326-1331.
104. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-33-3 not BCL-X. Cell. 1996;87:619-628.
105. Wang H-G, Rapp UR, J. C. R. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 1996;87:629-638.
106. Li Z, Bing OH, Long X, Robinson KG, Lakatta EG. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneoulsy hypertensive rat. Am J Physiol. 1997;272:H2313-H2319.
107. Thorburn J, Xu S, Thorburn A. MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. EMBO J. 1997;16:1888-1900.
108. Molnar A, Theodoras AM, Zon LI, Kyriakis JM. Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle pregression at G1/S through a mechanism requiring p38/RK. J Biol Chem. 1997;272:13229-13235.